Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management

doi:10.4254/wjh.v16.i4.550

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1286)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

HTML

858

Tables (1-3)

131

Sum=1041

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

133

Sum=164

Apr 27, 2024 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Apr 27, 2024; 16(4): 550-565
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.550

Table 3 Summary of the characteristics of quantitative hepatitis B antibody assays from several companies

Test names	Companies	Principle techniques	Detection methods	Range of detection
Anti-HBc QN[93]	Wantai BioPharm	Double-antigen sandwich	ELISA	0.1–25 IU/mL
Anti-HBc HQ[94]	United Medical Instruments	Fully automated two-step sandwich	CMIA	100–100000 IU/mL
Lumipulse G HBcAb-N[95]	Fujirebio Incorporation	Fully automated two-step sandwich	CLEIA	0.5–50 IU/mL
Europium III chelate microparticles HBcAb[96]	Guangzhou Darui Biotechnology	Rapid fluorescence POCT	LFIA	0-640 IU/mL

CLEIA: Chemiluminescent enzyme immunoassay; CMIA: Chemiluminescent microparticle immunoassay; ELISA: Enzyme-linked immunosorbent assay; HBcAb: Hepatitis B core antibody; HQ: High value quantitative detection; LFIA: Lateral flow immunoassay; POCT: Point-of-care test; QN: General value quantitative detection.

Citation: Leowattana W, Leowattana P, Leowattana T. Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management. World J Hepatol 2024; 16(4): 550-565
URL: https://www.wjgnet.com/1948-5182/full/v16/i4/550.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i4.550